Research Advances in Leptomeningeal Metastasis from Non-small Cell Lung Cancer
Leptomeningeal metastasis (LM) is a fatal complication of advanced non-small cell lung cancer (NSCLC), with poor prognosis and rapid deterioration of performance status. In recent years, substantial progress has been made in key aspects such as the establishment of leptomeningeal-related clinical an...
Main Authors: | LU Zhiqin, YUAN Yuanliang, LIU Anwen |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-12-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.20.0346.htm |
Similar Items
-
Management of Drug Therapy for Leptomeningeal Metastasis of Sensitive Driver Gene Positive Non-small Cell Lung Cancer
by: Zhiqin LU, et al.
Published: (2020-08-01) -
Analysis of Clinicopathological Feature and Prognosis for
Leptomeningeal Metastasis in Non-small Cell Lung Cancer
by: Min ZHU, et al.
Published: (2016-08-01) -
Diagnosis and Treatment of Leptomeningeal Metastasis in Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2015-10-01) -
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
by: Yali Yi, et al.
Published: (2022-03-01) -
CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
by: Xueying Wang, et al.
Published: (2023-02-01)